Targeting mutant estrogen receptors
A drug used in hormone replacement therapy can target estrogen receptors that have become resistant to breast cancer treatments.
Main Authors: | Suzanne E Wardell, John D Norris, Donald P McDonnell |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2019-01-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/44181 |
Similar Items
-
Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies
by: Rumeysa Ozyurt, et al.
Published: (2022-10-01) -
Role of Estrogen and Estrogen Receptor in GH-Secreting Adenomas
by: Giacomo Voltan, et al.
Published: (2023-06-01) -
New generation estrogen receptor-targeted agents in breast cancer: present situation and future prospectives
by: Jian Min, et al.
Published: (2024-03-01) -
Factors Influencing Skin Aging and the Important Role of Estrogens and Selective Estrogen Receptor Modulators (SERMs)
by: Lephart ED, et al.
Published: (2022-08-01) -
Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer
by: Niraj Neupane, et al.
Published: (2024-01-01)